Vanda Pharmaceuticals Inc (NASDAQ: VNDA) is 24.17% higher on its value in year-to-date trading and has touched a low of $3.30 and a high of $7.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VNDA stock was last observed hovering at around $4.05 in the last trading session, with the day’s gains setting it 1.19%.
Currently trading at $5.24, the stock is 25.40% and 26.39% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 23.95 million and changing 29.38% at the moment leaves the stock 15.49% off its SMA200. VNDA registered -19.88% loss for a year compared to 6-month loss of 18.82%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 39.73% gain in the last 1 month and extending the period to 3 months gives it a 39.36%, and is 22.43% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.70% over the week and 6.75% over the month.
Vanda Pharmaceuticals Inc (VNDA) has around 203 employees, a market worth around $301.51M and $192.64M in sales. Current P/E ratio is 119.91. Profit margin for the company is 1.30%. Distance from 52-week low is 59.03% and -25.14% from its 52-week high. The company has generated returns on investments over the last 12 months (0.45%).
The shares outstanding are 57.53M, and float is at 54.51M with Short Float at 4.56%.
Vanda Pharmaceuticals Inc (VNDA) Insider Activity
The most recent transaction is an insider sale by Polymeropoulos Mihael Hristos, the company’s President and CEO. SEC filings show that Polymeropoulos Mihael Hristos sold 24,288 shares of the company’s common stock on Mar 05 ’24 at a price of $4.13 per share for a total of $0.1 million. Following the sale, the insider now owns 1.87 million shares.
Vanda Pharmaceuticals Inc disclosed in a document filed with the SEC on Mar 05 ’24 that Wijkstrom Joakim (SVP, Chief Marketing Officer) sold a total of 9,229 shares of the company’s common stock. The trade occurred on Mar 05 ’24 and was made at $4.21 per share for $38830.0. Following the transaction, the insider now directly holds 0.13 million shares of the VNDA stock.
Still, SEC filings show that on Mar 05 ’24, Moran Kevin Patrick (SVP, CFO & Treasurer) disposed off 8,902 shares at an average price of $4.20 for $37411.0. The insider now directly holds 231,014 shares of Vanda Pharmaceuticals Inc (VNDA).
